arrow
Back
T

Thomas Bachelot

centre leon berard

65H-index
550Paper Count
2.4WCitation Count
Published Papers 196
Publication Date
Characteristics and outcomes of patients with HER2-negative metastatic breast cancers with low expression of estrogen and progesterone receptors in the multicenter ESME cohort.
err2026-05-18
err0
errOAAI
errMarie Alexandre; Eva Teruel; Florence Dalenc; Thibaut de la Motte Rouge; Etienne Brain; Vincent Massard; Monica Arnedos; Audrey Mailliez; Jean-Marc Ferrero; Thomas Bachelot; Isabelle Desmoulins; Marie-Ange Mouret-Reynier; Christelle Levy; Antony Gonçalves; Anca Berghian; Thierry Petit; Jean-Sébastien Frenel; Anne-Laure Martin; Thomas Grinda; William Jacot
errShare
errSave
Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial
err2026-04-03
err0
PREAI
errR. Dent; Z. Shao; P. Schmid; J. Cortes; D.W. Cescon; S. Saji; K.H. Jung; T. Bachelot; S. Wang; E.M. Ramírez; G. Basaran; A. Stradella; R. Mathiba; S.-C. Chen; K. Shen; Á. Wéber; N. Battelli; N. Niikura; T. Luo; Y.S. Chae
errShare
errSave
Recent treatment and survival trends in older versus younger women with HR-positive HER2-negative metastatic breast cancer in the real-life multicenter French ESME cohort
err2025-12-05
err0
PREAI
errFanny Bouteiller; Sophie Gourgou; Michaël Bringuier; Angéline Galvin; Audrey Mailliez; Nicolas Bertrand; Mony Hung; Jean-Sébastien Frenel; Vincent Massard; Thomas Bachelot; Carole Plumio; Anthony Gonçalves; Christelle Levy; Lise Bosquet; William Jacot; Suzette Delaloge; Thomas Grinda; Carine Bellera
errShare
errSave
Kinetics and determinants of ESR1 mutation detection in metastatic breast cancer
err2025-11-17
err0
PREAI
errL. Cabel; F. Berger; T. Bachelot; B. Pistilli; F. Dalenc; T.de la Motte Rouge; R. Sabatier; A. Lortholary; S. Marques; J. Vibert; S. Renault; A.C. Hardy-Bessard; S. Delaloge; A. Pradines; C. Callens; F.C. Bidard
errShare
errSave
Remotely supervised online cognitive training to reduce cognitive difficulties following chemotherapy in patients treated for localized breast cancer: Protocol of the Cog-Stim2 multicenter randomized controlled trial
err2025-11-13
err0
PREAI
errBousquet, Marie; Lange, Marie; Lequesne, Justine; Durand-Zaleski, Isabelle; Diaz, Olivia; Di Meglio, Antonio; Bachelot, Thomas; Grellard, Jean-Michel; Clarisse, Benedicte; Joly, Florence
errShare
errSave
errShare
errSave
Real-world treatment patterns and effectiveness after disease progression on CDK4/6 inhibitors for HR-positive/HER2-negative metastatic breast cancer in the ESME-MBC cohort
err2025-09-17
err0
PREAI
errR. Varnier; D. Pérol; W. Jacot; A. Mailliez; V. Diéras; F. Dalenc; A. Gonçalves; C. Levy; M. Arnedos; J.-S. Frenel; C. Bailleux; V. Massard; E. Brain; B. Sauterey; A.-M. Savoye; L. Bosquet; J.-C. Thery; T. Petit; T. Bachelot; T. Grinda; I. Ray-Coquard
errShare
errSave
Discovery of epigenetically silenced tumour suppressor genes in aggressive breast cancer through a computational approach
err2025-06-01
err0
errOAAI
errVitte, Anne-Laure; Chuffart, Florent; Jacquet, Emmanuelle; Nika, Eleni; Mousseau, Mireille; Jung, Ina; Tabone-Eglinger, Severine; Bachelot, Thomas; Rousseaux, Sophie; Khochbin, Saadi; Bourova-Flin, Ekaterina
errShare
errSave
CAMBRIA-1 & CAMBRIA-2 phase III trials: camizestrant versus standard endocrine therapy in ER+/HER2-early breast cancer
err2025-02-27
err0
errOAAI
errHamilton, Erika P.; Loibl, Sibylle; Bachelot, Thomas; Gnant, Michael; Niikura, Naoki; Park, Yeon Hee; Tolaney, Sara M.; Pistilli, Barbara; Rastogi, Priya; Saini, Kamal S.; Gioni, Ioanna; Johnston, Simon; Nunes, Raquel; Quintana, Angela; Stuart, Mary; Syta, Emilia; Walding, Andrew; Klinowska, Teresa; Mayer, Ingrid A.
errShare
errSave
Expert HER2-positive Volkmar Julia Emilie a The University b Centre c Department
err2025-01-01
err0
errOAAI
errMueller, Volkmar; Bachelot, Thomas; Curigliano, Giuseppe; de Azambuja, Evandro; Furtner, Julia; Gempt, Jens; Jereczek-Fossa, Barbara Alicja; Jerzak, Katarzyna J.; Le Rhun, Emilie; Palmieri, Carlo; Pravettoni, Gabriella; Saura, Cristina; Bartsch, Rupert
errShare
errSave
Assessing the real-world effectiveness of 8 major metastatic breast cancer drugs using target trial emulation☆
err2024-12-01
err0
errOAAI
errAntoine, Alison; Perol, David; Robain, Mathieu; Bachelot, Thomas; Choquet, Remy; Jacot, William; Yahia, Bechir Ben Hadj; Grinda, Thomas; Delaloge, Suzette; Lasset, Christine; Drouet, Youenn
errShare
errSave
Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitors
err2024-08-02
err0
errOAAI
errSablin, Marie-Paule; Gestraud, Pierre; Jonas, Sarah Flora; Lamy, Constance; Lacroix-Triki, Magali; Bachelot, Thomas; Filleron, Thomas; Lacroix, Ludovic; Tran-Dien, Alicia; Jezequel, Pascal; Mauduit, Marjorie; Barros Monteiro, Janice; Jimenez, Marta; Michiels, Stefan; Attignon, Valery; Soubeyran, Isabelle; Driouch, Keltouma; Servant, Nicolas; Le Tourneau, Christophe; Kamal, Maud; Andre, Fabrice; Bieche, Ivan
errShare
errSave
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial
err2024-06-02
err6
errOAAI
errCortes, Javier; Hurvitz, Sara A.; Im, Seock-Ah; Iwata, Hiroji; Curigliano, Giuseppe; Kim, Sung-Bae; Chiu, Joanne W. Y.; Pedrini, Jose L.; Li, Wei; Yonemori, Kan; Bianchini, Giampaolo; Loi, Sherene; Borges, Giuliano S.; Wang, Xian; Bachelot, Thomas; Nakatani, Shunsuke; Ashfaque, Shahid; Liang, Zhengkang; Egorov, Anton; Hamilton, Erika
errShare
errSave
Pathological complete response with chemotherapy and immune checkpoint inhibition in triple negative inflammatory breast cancer (TN-IBC)
err2024-05-02
err0
PREAI
errLynce, Filipa; Niman, Samuel; Goncalves, Anthony; Kai, Megumi; Ryan, Sean; Troll, Elizabeth; Layman, Rachel; Giordano, Antonio; Nasrazadani, Azadeh; Nakhlis, Faina; Bellon, Jennifer; Warren, Laura; Block, Caroline; Schumer, Susan; Lucci, Anthony; Krishnamurthy, Savitri; Lerebours, Florence; Dalenc, Florence; Levy, Christelle; Petit, Thierry; Leheurteur, Marianne; Bachelot, Thomas; Tredan, Olivier; Ladoire, Sylvain; Almeida, Leonor Lopez; Zemmour, Christophe; Tolaney, Sara; Valero, Vicente; Bertucci, Francois; Regan, Meredith; Woodward, Wendy
errShare
errSave
Trial in progress: Open-label, randomized, multicenter, phase 3, ELAINE 3 study of the efficacy and safety of lasofoxifene plus abemaciclib for treating locally advanced or ER+/HER2-metastatic breast cancer with an ESR1 mutation
err2024-05-02
err0
PREAI
errGoetz, Matthew; Wander, Seth; Bachelot, Thomas; Batist, Gerald; Cortes, Javier; Cristofanilli, Massimo; Curigliano, Giuseppe; de Nonneville, Alexandre; Yam, Einav Nili-Gal; Jhaveri, Komal; Ma, Cynthia; Parsons, Heather; Rugo, Hope; Sammons, Sarah; Stover, Daniel; Twelves, Chris; Bardia, Aditya; Plourde, Paul V.; Portman, David J.; Damodaran, Senthil
errShare
errSave
ASTEFANIA: a Phase III study of ado- trastuzumab emtansine plus atezolizumab or placebo as adjuvant therapy in patients with residual invasive breast cancer after neoadjuvant HER2-targeted therapy and chemotherapy
err2024-05-02
err0
PREAI
errSchmid, Peter; Bachelot, Thomas; Bianchini, Giampaolo; Harbeck, Nadia; Loi, Sherene; Park, Yeon; Prat, Aleix; Gilham, Leslie; Boulet, Thomas; Gochitashvili, Nino; Monturus, Estefania; Lambertini, Chiara; Nyawira, Beatrice; Knott, Adam; Hurvitz, Sara
errShare
errSave
Prognostic value of EndoPredict test in patients with hormone receptorpositive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trial
err2024-05-01
err0
errOAAI
errPenault-Llorca, F.; Dalenc, F.; Chabaud, S.; Cottu, P.; Allouache, D.; Cameron, D.; Grenier, J.; Bouvet, L. Venat; Jegannathen, A.; Campone, M.; Debled, M.; Hardy-Bessard, A. -C.; Giacchetti, S.; Barthelemy, P.; Kaluzinski, L.; Mailliez, A.; Mouret-Reynier, M. -A.; Legouffe, E.; Cayre, A.; Martinez, M.; Delbaldo, C.; Mollon-Grange, D.; Macaskill, E. J.; Sephton, M.; Stefani, L.; Belgadi, B.; Winter, M.; Orfeuvre, H.; Lacroix-Triki, M.; Bonnefoi, H.; Bliss, J.; Canon, J. -l.; Lemonnier, J.; Andre, F.; Bachelot, T.
errShare
errSave
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane
err2024-01-05
err0
PREAI
errVanacker, Helene; Treilleux, Isabelle; Schiffler, Camille; Bieche, Ivan; Campone, Mario; Patsouris, Anne; Arnedos, Monica; Cottu, Paul H.; Jacquin, Jean-Philippe; Dalenc, Florence; Pinton, Antoine; Servant, Nicolas; Attignon, Valery; Rouleau, Etienne; Morel, Alain; Legrand, Francois; Jimenez, Marta; Andre, Fabrice; Bachelot, Thomas
errShare
errSave
First-line real-world treatment patterns and survival outcomes in women younger or older than 40 years with metastatic breast cancer in the real-life multicenter French ESME cohort
err2024-01-01
err4
PREAI
errGalvin, Angeline; Courtinard, Coralie; Bouteiller, Fanny; Gourgou, Sophie; Dalenc, Florence; Jacot, William; Arnedos, Monica; Bailleux, Caroline; Dieras, Veronique; Petit, Thierry; Emile, George; Dubray-Longeras, Pascale; Frenel, Jean-Sebastien; Bachelot, Thomas; Mailliez, Audrey; Brain, Etienne; Desmoulins, Isabelle; Massard, Vincent; Patsouris, Anne; Goncalves, Anthony; Grinda, Thomas; Delaloge, Suzette; Bellera, Carine
errShare
errSave